Clinical trial

Vaccine Therapy in Treating Patients With Metastatic Breast Cancer

NCT00071942

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

BIOLOGICAL · Unmapped registry intervention recombinant vaccinia-MUC1 vaccine Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention recombinant vaccinia-TRICOM vaccine Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention laboratory biomarker analysis Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention quality-of-life assessment Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Vaccine Therapy in Treating Patients With Metastatic Breast Cancer

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2003-10-01

PhasePHASE1

Conditions

Male Breast Cancerverified · MONDO: male breast carcinoma

Recurrent Breast Cancerunresolved

Stage IV Breast Cancerunresolved

Interventions

recombinant vaccinia-MUC1 vaccineBIOLOGICAL

recombinant vaccinia-TRICOM vaccineBIOLOGICAL

laboratory biomarker analysisOTHER

quality-of-life assessmentPROCEDURE

Sponsors & collaborators

National Cancer Institute (NCI)lead sponsor

Mapped research locations

BostonMassachusetts, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00071942 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.